Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA plus interferon-γ-induced apoptosis in primary pancreatic β-cells

被引:137
作者
Rasschaert, J
Ladrière, L
Urbain, M
Dogusan, Z
Katabua, B
Sato, S
Akira, S
Gysemans, C
Mathieu, C
Eizirik, DL
机构
[1] Univ Libre Bruxelles, Expt Med Lab, B-1070 Brussels, Belgium
[2] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan
[3] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium
关键词
D O I
10.1074/jbc.M502213200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Viral infections and local production of cytokines probably contribute to the pathogenesis of Type 1 diabetes. The viral replicative intermediate double-stranded RNA ( dsRNA, tested in the form of polyinosinic-polycytidylic acid, PIC), in combination with the cytokine interferon-gamma (IFN-gamma), triggers beta-cell apoptosis. We have previously observed by microarray analysis that PIC induces expression of several mRNAs encoding for genes downstream of Toll-like receptor 3 (TLR3) signaling pathway. In this report, we show that exposure of beta-cells to dsRNA in combination with IFN-alpha, -beta, or -gamma significantly increases apoptosis. Moreover, dsRNA induces TLR3 mRNA expression and activates NF-kappa B and the IFN-beta promoter in a TRIF-dependent manner. dsRNA also induces an early ( 1 h) and sustained increase in IFN-beta mRNA expression, and blocking IFN-beta with a specific antibody partially prevents PIC plus IFN-gamma-induced beta-cell death. On the other hand, dsRNA plus IFN-gamma does not induce apoptosis in INS-1E cells, and expression of TLR3 and type I IFNs mRNAs is not detected in these cells. Of note, disruption of the STAT-1 signaling pathway protects beta-cells against dsRNA plus IFN-gamma-induced beta-cell apoptosis. This study suggests that dsRNA plus IFN-gamma triggers beta-cell apoptosis by two complementary pathways, namely TLR3-TRIF-NF-kappa B and STAT-1.
引用
收藏
页码:33984 / 33991
页数:8
相关论文
共 69 条
[1]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[2]   IFNβ accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to β cells in nondiabetes-prone mice [J].
Alba, A ;
Puertas, MC ;
Carrillo, J ;
Planas, R ;
Ampudia, R ;
Pastor, X ;
Bosch, F ;
Pujol-Borrell, R ;
Verdaguer, J ;
Vives-Pi, M .
JOURNAL OF IMMUNOLOGY, 2004, 173 (11) :6667-6675
[3]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[4]   ESTABLISHMENT OF 2-MERCAPTOETHANOL-DEPENDENT DIFFERENTIATED INSULIN-SECRETING CELL-LINES [J].
ASFARI, M ;
JANJIC, D ;
MEDA, P ;
LI, GD ;
HALBAN, PA ;
WOLLHEIM, CB .
ENDOCRINOLOGY, 1992, 130 (01) :167-178
[5]  
Besser D, 1999, MOL CELL BIOL, V19, P1401
[6]   Inferences, questions and possibilities in toll-like receptor signalling [J].
Beutler, B .
NATURE, 2004, 430 (6996) :257-263
[7]   Cell-permeable peptide inhibitors of JNK novel blockers of β-cell death [J].
Bonny, C ;
Oberson, A ;
Negri, S ;
Sauser, C ;
Schorderet, DF .
DIABETES, 2001, 50 (01) :77-82
[8]   IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice [J].
Cardozo, AK ;
Proost, P ;
Gysemans, C ;
Chen, MC ;
Mathieu, C ;
Eizirik, DL .
DIABETOLOGIA, 2003, 46 (02) :255-266
[9]   Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays [J].
Cardozo, AK ;
Kruhoffer, M ;
Leeman, R ;
Orntoft, T ;
Eizirik, DL .
DIABETES, 2001, 50 (05) :909-920
[10]   Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells [J].
Delaney, CA ;
Pavlovic, D ;
Hoorens, A ;
Pipeleers, DG ;
Eizirik, DL .
ENDOCRINOLOGY, 1997, 138 (06) :2610-2614